[1]陈智鸿王莉林丽瑜李彩凤林雪萍谢起雯林琳邱珊芳滕杰.2022年度厦门市肾病专业质量控制数据分析[J].中国卫生质量管理,2023,30(07):018-23.[doi:10.13912/j.cnki.chqm.2023.30.7.05 ]
　CHEN Zhihong,WANG Li,LIN Liyu.Analysis of Quality Control Data of Nephrology in Xiamen in 2022[J].Chinese Health Quality Management,2023,30(07):018-23.[doi:10.13912/j.cnki.chqm.2023.30.7.05 ]
点击复制

2022年度厦门市肾病专业质量控制数据分析
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第30卷
期数:
2023年07期
页码:
018-23
栏目:
医疗质量
出版日期:
2023-07-15

文章信息/Info

Title:
Analysis of Quality Control Data of Nephrology in Xiamen in 2022
作者:
陈智鸿王莉林丽瑜李彩凤林雪萍谢起雯林琳邱珊芳滕杰
复旦大学附属中山医院厦门医院
Author(s):
CHEN Zhihong; WANG Li; LIN Liyu
Xiamen Branch,Zhongshan Hospital
关键词:
厦门市; 肾脏病专科; 质量控制; 质控中心
Keywords:
Xiamen; Department of Nephrology; Quality Control; Quality Control Center
分类号:
R197.323；R692
DOI:
10.13912/j.cnki.chqm.2023.30.7.05
文献标志码:
A
摘要:
目的调查厦门市肾病专业质控数据，了解该市肾病学科发展规模及诊疗现状，为患者提供更加安全、可靠、高质量的医疗服务。方法厦门市肾病专业质量控制中心对13家医院2022年度专业质控数据进行采集、整理和描述性分析。结果共有肾脏专科医生156名，护士397名，透析工程师17名，肾病专科床位393张，透析相关设备623台。肾脏病专科门诊共接诊134 283例患者，年度住院患者8 154例；年度内手术操作累计3 457例次；住院患者中，分别有4.39%慢性肾脏病患者和46.56%急性肾损伤患者未接受分期评估。前3位的肾小球疾病分别为糖尿病肾病（1 154例）、IgA肾病（881例）和膜性肾病（740例）。糖尿病肾病患者糖化血红蛋白达标率为46.50%，低密度脂蛋白胆固醇达标率为53.62%；接受肾穿刺的IgA肾病随访患者中，血压和尿蛋白达标率分别为81.74%、62.60%，但有2.10％的患者出现肾功能恶化。结论厦门市肾病专业质控工作仍处于初级阶段，今后需重点加强肾病专科护士队伍建设，完善质控信息采集，规范肾功能分期诊断，提高重点病种管理水平。
Abstract:
ObjectiveTo investigate the professional quality control data of nephrology in Xiamen, explore the development scale and diagnosis and treatment status of nephrology, and provide more safe, reliable and high-quality medical services for patients.MethodsThe 2022 quality control data of 13 hospitals were collected, sorted and analyzed by Xiamen Nephrology Quality Control Center.ResultsThere were 156 physicians of nephrology, 397 nurses, 17 dialysis engineers, 393 beds of nephrology and 623 dialysis-related equipment in the city. A total of 134 283 patients were treated in the specialized outpatient department of kidney disease, including 8 154 inpatients annually. A total of 3 457 surgical operations were performed annually. Among hospitalized patients, 4.39% of patients with chronic kidney disease and 46.56% of patients with acute kidney injury did not receive staging assessment, respectively. The top 3 glomerular diseases were diabetic nephropathy (1 154 cases), IgA nephropathy (881 cases) and membranous nephropathy (740 cases). 46.50% of diabetic nephropathy patients met the standard of glycosylated hemoglobin and 53.62% of low-density lipoprotein. In IgA nephropathy patients receiving renal puncture, 81.74% and 62.60% of blood pressure and urine protein reached the standard, respectively, but 2.10% of patients showed deterioration of renal function.Conclusion The quality control of Nephrology in Xiamen is still at an early stage. In the future, emphasis should be placed on strengthening the construction of the nephrology specialized nursing team, improving the collection of quality control information, standardizing the staging diagnosis of kidney function, and improving the management level of key diseases.

参考文献/References:

［1］WEBSTER AC, NAGLER EV, MORTON RL, et al. Chronic Kidney Disease［J］. Lancet, 2017, 389(10075): 1238-1252. ［2］COLLABORATION G, TRAN K, YAMADA T. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017［J］. Lancet, 2020, 395(10225): 709-733. ［3］SHLIPAK MG, TUMMALAPALLI SL, BOULWARE LE, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference［J］. Kidney Int, 2021, 99(1): 34-47. ［4］上海市肾内科临床质量控制中心专家组. 慢性肾脏病早期筛查、诊断及防治指南(2022年版)［J］. 中华肾脏病杂志, 2022, 38(5): 453-464. ［5］国家卫生健康委医政医管局.2021年国家医疗质量安全改进目标［J］. 中国卫生质量管理, 2021, 28(4): 15. ［6］陈香美.血液净化标准操作规程(2021版)［M］.北京：人民卫生出版社，2021:11. ［7］陈香美.腹膜透析标准操作规程［M］.北京：人民军医出版社，2011:4. ［8］WEINHANDL ED, SAFFER TL, ARAGON M. Hidden costs associated with conversion from peritoneal dialysis to hemodialysis［J］. Kidney360, 2022, 3(5): 883-890. ［9］陈 彬, 孙承斌, 周建波, 等. 3种不同腹膜透析置管手术方式的对比研究［J］. 中华危重病急救医学, 2021, 33(9): 1084-1087. ［10］BELLO AK, ALRUKHAIMI M, ASHUNTANTANG GE, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action［J］. Kidney Int Suppl (2011), 2017, 7(2): 122-129. ［11］SEE EJ, JAYASINGHE K, GLASSFORD N, et al. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure［J］. Kidney Int, 2019, 95(1): 160-172.［12］DE BOER IH, KHUNTI K, SADUSKY T, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and kidney disease: Improving Global Outcomes (KDIGO)［J］. Diabetes Care, 2022, 45(12): 3075-3090. ［13］中华医学会糖尿病学分会微血管并发症学组. 中国糖尿病肾脏病防治指南(2021年版)［J］. 中华糖尿病杂志, 2021, 13(8): 762-784. ［14］PENFOLD RS, PRENDECKI M, MCADOO S, et al. Primary IgA nephropathy: current challenges and future prospects［J］. Int J Nephrol Renovasc Dis, 2018, 11: 137-148. ［15］INKER LA, HEERSPINK HJL, TIGHIOUART H, et al. Association of treatment effects on early change in urine protein and treatment effects on GFR slope in IgA nephropathy: an individual participant meta-analysis［J］. Am J Kidney Dis, 2021, 78(3): 340-349. ［16］DISEASE K, OUTCOMES IG, GROUP G. KDIGO 2021 Clinical practice guideline for the management of glomerular diseases［J］. Kidney Int, 2021, 100(4S): S1-S276.

更新日期/Last Update: 2023-07-15